Skip to main content
. 2021 Mar 18;65(4):e01618-20. doi: 10.1128/AAC.01618-20

FIG 1.

FIG 1

Representative time-concentration profiles for simulated human once-daily dosing regimens of anidulafungin (AFG), caspofungin (CAS), and micafungin (MFG) in an in vitro pharmacokinetic/pharmacodynamic (PK/PD) model with target maximum concentration (fCmax) of 4 mg/liter. Data represent drug levels in the internal compartment of the in vitro model (solid lines) and the respective target values observed in human serum (broken lines).